Part of: Prelims and GS-III- Economy Context Directorate General of Trade Remedies (DGTR) has recommended the imposition of anti-dumping duty on a pharma raw material — Ceftriaxone Sodium Sterile — from China to guard local players from cheap imports.
- Ceftriaxone Sodium Sterile is an API used in formulation for treating diseases such as lower respiratory tract infection, skin and surgical prophylaxis.
- The Finance Ministry will take the final decision on imposing the duty.
About the DGTR authority
- DGTR functions as an attached office of the Department of Commerce, Ministry of Commerce and Industry.
- DGTR deals with Anti-dumping, Countervailing Duty (CVD) and Safeguard measures.
- It also provides trade defence support to our domestic industry and exporters in dealing with increasing instances of trade remedy investigations instituted against them by other countries.
- DGTR provides a level playing field to the domestic industry against the adverse impact of the unfair trade practices
About Anti-dumping Duty
- An anti-dumping duty is a protectionist tariff that a domestic government imposes on foreign imports that it believes are dumped.
- The imposition of anti-dumping duty is permissible under the World Trade Organization regime.
- It is aimed at ensuring fair trading practices and creating a level-playing field for local producers vis-a-vis foreign producers and exporters.
- These tariffs can also lead to higher prices for domestic consumers.
What is Active Pharmaceutical Ingredient (API)?
- Part of any drug that produces its effects.
- Intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease.